Veterinary Medicines

Bioclanic 250 mg + 62.5 mg flavoured tablets for cats and dogs

Authorised
  • Amoxicillin trihydrate
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
Download as PDF

Product identification

Medicine name:
Bioclanic 250 mg + 62.5 mg flavoured tablets for cats and dogs
Bioclanic 250 mg + 62,5 mg comprimés aromatisés pour chats et chiens
Bioclanic 250 mg + 62,5 mg tabletten met smaakstof voor katten en honden
Bioclanic 250 mg + 62,5 mg aromatisierte Tabletten für Katzen und Hunde
Active substance:
  • Amoxicillin trihydrate
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
Target species:
  • Dog
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    286.98
    milligram(s)
    /
    1.00
    Tablet
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
    148.91
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CR02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: cardboard box of 10 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: cardboard box of 20 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: cardboard box of 30 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: cardboard box of 40 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: cardboard box of 50 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: cardboard box of 100 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: cardboard box of 150 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: cardboard box of 200 tablets.
  • oPA/Alu/PVC - PVC/Alu heat sealed blister containing 10 tablets each. Package sizes: cardboard box of 250 tablets.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application – change in strength (Article 19(1)(a) of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Axience
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V663441
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0788/002
Concerned member states:
  • Austria
  • Belgium
  • Cyprus
  • Greece
  • Hungary
  • Italy
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain

Documents

Summary of Product Characteristics

English (PDF)
Published on: 28/09/2025
Download
Dutch (PDF)
Published on: 28/01/2026
Download
French (PDF)
Published on: 28/01/2026
Download
German (PDF)
Published on: 28/01/2026
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 14/10/2025
Download
French (PDF)
Published on: 14/10/2025
Download
German (PDF)
Published on: 14/10/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 28/01/2026
Download
French (PDF)
Published on: 28/01/2026
Download
German (PDF)
Published on: 28/01/2026
Download

ie-puar-mr-iev0788002-bioclanic-250-mg--625-mg-flavoured-tablets-for-cat-en.pdf

English (PDF)
Published on: 28/09/2025
Download